DK1056462T3 - Anvendelse af rhamnolipider som kosmetiske midler - Google Patents

Anvendelse af rhamnolipider som kosmetiske midler

Info

Publication number
DK1056462T3
DK1056462T3 DK99936031T DK99936031T DK1056462T3 DK 1056462 T3 DK1056462 T3 DK 1056462T3 DK 99936031 T DK99936031 T DK 99936031T DK 99936031 T DK99936031 T DK 99936031T DK 1056462 T3 DK1056462 T3 DK 1056462T3
Authority
DK
Denmark
Prior art keywords
treatment
rhamnolipids
prevention
cosmetics
schizophrenia
Prior art date
Application number
DK99936031T
Other languages
English (en)
Inventor
Tatjana Piljac
Goran Piljac
Original Assignee
Paradigm Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paradigm Biomedical Inc filed Critical Paradigm Biomedical Inc
Application granted granted Critical
Publication of DK1056462T3 publication Critical patent/DK1056462T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
DK99936031T 1998-02-24 1999-02-24 Anvendelse af rhamnolipider som kosmetiske midler DK1056462T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7595998P 1998-02-24 1998-02-24
PCT/US1999/003714 WO1999043334A1 (en) 1998-02-24 1999-02-24 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics

Publications (1)

Publication Number Publication Date
DK1056462T3 true DK1056462T3 (da) 2007-12-03

Family

ID=22129018

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99936031T DK1056462T3 (da) 1998-02-24 1999-02-24 Anvendelse af rhamnolipider som kosmetiske midler

Country Status (10)

Country Link
US (2) US20070155678A1 (da)
EP (1) EP1056462B1 (da)
JP (2) JP2002504513A (da)
AT (1) ATE367797T1 (da)
AU (1) AU747088B2 (da)
CA (1) CA2321926C (da)
DE (1) DE69936635T2 (da)
DK (1) DK1056462T3 (da)
ES (1) ES2291036T3 (da)
WO (1) WO1999043334A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE473749T1 (de) 1999-08-05 2010-07-15 Paradigm Biomedical Inc Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration
WO2008013899A2 (en) * 2006-07-27 2008-01-31 Aurora Advance Beauty Labs Rhamnolipid-based formulations
AU2007313580B8 (en) * 2006-10-17 2010-08-26 Idemitsu Kosan Co., Ltd. Animal feed additive and animal feed
JO3416B1 (ar) 2009-04-27 2019-10-20 Jeneil Biosurfactant Co Llc تركيبات مضادة للبكتيريا وطرق استخدامها
US10434058B2 (en) 2010-12-09 2019-10-08 Y&B Mother's Choice Ltd. Natural formulations
EP2648809B1 (en) 2010-12-09 2019-04-03 Y&B Mother's Choice Ltd. Natural formulations
EP2648742B1 (en) 2010-12-09 2019-04-24 Y&B Mother's Choice Ltd. Formulations comprising saponins and uses thereof
WO2012177593A2 (en) 2011-06-21 2012-12-27 Rhamnopharma Inc. Method for treating obesity
KR20200044153A (ko) 2013-03-15 2020-04-28 제네일 바이오서팩턴트 컴파니, 엘엘씨 항균성 조성물들 및 관련된 사용 방법
BR112015025049B1 (pt) 2013-04-25 2021-03-09 Unilever Ip Holdings B.V. composição fluida de limpeza
IL229836A0 (en) 2013-12-08 2014-03-31 Y & B Mother S Choice Ltd Formulations to reduce or suppress irritation to eye tissue
CN105326848A (zh) * 2015-11-26 2016-02-17 浙江大学 一种鼠李糖脂在制备抗纤维化药物制剂中的用途
BR102017000578B1 (pt) 2017-01-11 2019-04-02 Natura Cosméticos S.A. Processo de obtenção de ramnolipídeo produzido por pseudomonas ou enterobacter utilizando o resíduo de semente de andiroba ou murumuru
WO2020247808A1 (en) * 2019-06-07 2020-12-10 Dale Biotech, Llc Method for treating dupuytren's disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3405664A1 (de) * 1984-02-17 1985-09-05 Wintershall Ag, 3100 Celle Verfahren zur biotechnischen herstellung von rhamnolipiden und rhamnolipide mit nur einem ss-hydroxidecancarbonsaeurerest im molekuel
JPS63182029A (ja) * 1987-01-22 1988-07-27 Agency Of Ind Science & Technol リポソ−ム
US4933281A (en) * 1987-03-17 1990-06-12 The University Of Iowa Research Foundation Method for producing rhamnose
JPS63253025A (ja) * 1987-04-09 1988-10-20 Yamanouchi Pharmaceut Co Ltd ホスホリパ−ゼａ↓２阻害剤
EP0288965A2 (de) * 1987-04-29 1988-11-02 Hoechst Aktiengesellschaft Peptide mit Phospholipase A2- hemmender Wirkung
DE4030262A1 (de) * 1990-09-25 1992-03-26 Suedzucker Ag Verfahren zur herstellung von rhamnose aus rhamnolipiden
BE1005704A4 (nl) * 1992-02-04 1993-12-21 Piljac Goran & Piljac Visnja Farmaceutisch preparaat op basis van rhamnolipide.
US5455232A (en) * 1992-02-04 1995-10-03 Piljac; Goran Pharmaceutical preparation based on rhamnolipid
US5466675A (en) * 1992-02-04 1995-11-14 Piljac; Goran Immunological activity of rhamnolipids

Also Published As

Publication number Publication date
AU747088B2 (en) 2002-05-09
AU3304899A (en) 1999-09-15
US20070155678A1 (en) 2007-07-05
JP2002504513A (ja) 2002-02-12
DE69936635D1 (de) 2007-09-06
ES2291036T3 (es) 2008-02-16
CA2321926C (en) 2010-04-27
ATE367797T1 (de) 2007-08-15
CA2321926A1 (en) 1999-09-02
DE69936635T2 (de) 2008-05-08
JP2011001373A (ja) 2011-01-06
US20090220603A1 (en) 2009-09-03
WO1999043334A1 (en) 1999-09-02
EP1056462A4 (en) 2004-12-01
EP1056462B1 (en) 2007-07-25
EP1056462A1 (en) 2000-12-06

Similar Documents

Publication Publication Date Title
DK1056462T3 (da) Anvendelse af rhamnolipider som kosmetiske midler
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
NO20013442L (no) Sammensetninger som oppnar en forbedret levering av aktive stoffer
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
AR019503A1 (es) Utilizacion de derivados sustituidos en 3 del estilbeno como agentes activos desodorantes en las composiciones cosmeticas
ES2099056T1 (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
DE59108530D1 (de) Antimikrobielle Mittel sowie substituierte 2-Cyclohexan-1-yl-amin-Derivate und deren Herstellung
DK1440148T3 (da) Keratinocytter anvendelige som biologisk aktive substanser i behandling af sår
CA2306040A1 (en) Coloring agent-containing sunless tanning compositions
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
CA2148988A1 (fr) Utilisation d'extraits de bacteries filamenteuses comme agents cosmetiques contre le vieillissement cutane
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DE50007791D1 (de) Parfümkomposition mit duftsequenz
MY122877A (en) Composition.
ATE314084T1 (de) Kahalalid f formulierung
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
AR004077A1 (es) Una composicion particularmente cosmetica, y mas particularmente para la deformacion permanente de las fibras queratinicas.
EP1889623A3 (en) Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
AR023511A1 (es) Composicion que comprende (s) y (r) 5-amino-3-ciano-1-(2,6-dicloro-4-trifluorometilfenil)-4-trifluoro-metilsulfinilpirazol, dichos compuestos aislados y usos de los mismos como plaguicida
BRPI0406734A (pt) Composição termiticida, e, método para controlar térmitas
ES2133918T3 (es) Nuevos esteroides seco-d activos en el sistema cardiovascular y composiciones farmaceuticas que los contienen.
AR004484A1 (es) Nuevas 1,2,3,4-tetrahidro-2-naftalenaminas fenilo-sustituidas en el anillo aromatico, su preparacion, sus aplicaciones terapeuticas y las composicionesfarmaceuticas que las contienen.
RS49955B (sr) Stabilne kompozicije koje sadrže levosimendan i alginsku kiselinu
AU2811400A (en) Stable formulation containing fumagillin